Market Place
Sourcing Support
TuHURA Biosciences Names Garofalo SVP of Clinical Operations
07 Apr 2026 //
PR NEWSWIRE
Tuhura Biosciences Reveals 2025 Financials And Corporate Update
01 Apr 2026 //
PR NEWSWIRE
Ex-J&J Exec Tendler to Lead TuHURA`s VISTA Program in AML
23 Mar 2026 //
PR NEWSWIRE
Tuhura Bio Restores Nasdaq Bid Price Compliance Requirement
27 Feb 2026 //
PR NEWSWIRE
Tuhura Submits Ind For TBS-2025 In Blood Cancer Treatment
17 Feb 2026 //
PR NEWSWIRE
TuHURA Bio to Present at Oppenheimer Healthcare Conference
12 Feb 2026 //
PR NEWSWIRE
Tuhura Biosciences Granted FDA Orphan Status For IFX-2.0
02 Feb 2026 //
PR NEWSWIRE
TuHURA Presents DOR as ICI Resistance Target at 57th ASH Meeting
08 Dec 2025 //
PR NEWSWIRE
Tuhura Biosciences Targets (DOR) To Reprogram MDSCs at ASH
03 Nov 2025 //
PR NEWSWIRE
TuHURA Biosciences to Speak at 27th HC Wainwright Conference
20 Aug 2025 //
PR NEWSWIRE
TuHura Biosciences Reports Q2 2025 Financials, Corporate Update
14 Aug 2025 //
PR NEWSWIRE
TuHURA Biosciences Joins Russell 3000 and Russell 2000 Indexes
01 Jul 2025 //
PR NEWSWIRE
TuHURA Biosciences Completes Acquisition of Kineta
30 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences Begins Phase 3 Trial of IFx-2.0 with Keytruda®
24 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences, Kineta Stockholders Approve Merger
23 Jun 2025 //
PR NEWSWIRE
TuHURA Biosciences, Inc. Reports Q1 2025 Results and Update
15 May 2025 //
PR NEWSWIRE
TuHURA Biosciences & Kineta Present Updated Results at AACR Meeting
28 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Abstracts Accepted for 2025 AACR Meeting
08 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Names Dr. Bertrand Le Bourdonnec EVP, He
07 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences Reports Fiscal Year 2024 Results
01 Apr 2025 //
PR NEWSWIRE
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D. to Board
11 Mar 2025 //
ACCESSWIRE
TuHURA Biosciences to Present at 37th Annual ROTH Conference
10 Mar 2025 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.